Results 201 to 210 of about 119,519 (336)
Acute retinal necrosis during the systemic use of Janus kinase inhibitor. [PDF]
Int J Retina VitreousWatanabe D +12 more
europepmc +1 more source
Development of a Formulation and In Vitro Evaluation of a Pulmonary Drug Delivery System for a Novel Janus Kinase (JAK) Inhibitor, CPL409116 [PDF]
Aleksandra Rzewińska +8 more
openalex +1 more source
Evaluation of a Janus kinase 1 inhibitor, PF‐04965842, in healthy subjects: A phase 1, randomized, placebo‐controlled, dose‐escalation study [PDF]
, 2018 Elena Peeva +7 more
openalex +1 more source
Intramolecular regulation of Janus kinases
, 2017 Janus-kinaasit (JAKit) ovat ei-reseptorisia tyrosiinikinaaseja, jotka välittävät yli 60 sytokiinin viestejä soluissa. Nämä viestit säätelevät lukuisia biologisia tapahtumia, kuten immuunijärjestelmän toimintaa, hematopoieesia, aineenvaihduntaa sekä kehitystä.
openaire +2 more sources
Citation: 'Janus-family tyrosine kinase' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13352 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual ...
openaire +1 more source
The Journal of Dermatology, EarlyView.ABSTRACT Tralokinumab, an anti‐IL‐13 antibody, is effective for atopic dermatitis (AD); however, its long‐term (> 1 year) effectiveness specific to each anatomical site is unknown in real‐world settings. To evaluate 72‐week effectiveness of tralokinumab on different anatomical sites in AD, we studied 208 patients with moderate‐to‐severe AD treated with
Mizuki Shiba +6 more
wiley +1 more source
Janus kinase/signal transducer and activator of transcription pathway in schizophrenia (Review). [PDF]
Biomed RepRizos E +4 more
europepmc +1 more source
Janus Kinases Affect Thrombopoietin Receptor Cell Surface Localization and Stability [PDF]
, 2005 Yohan Royer +4 more
openalex +1 more source